Physician

Carlos P Torres, M.D.

According to 2025 Medicare claims, Carlos Torres, M.D. (NPI: 1396701819) practices radiation oncology in the Lubbock, TX market, with the plurality of this provider's patient population coming from Lubbock, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 79416-3035.

Torres' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 124 traditional Medicare patients, billed 4,490 HCPCS/CPT codes, and received $723,901 in Medicare payments. The top billing code was 77427 (Radiation treatment management, 5 treatment sessions). Part D data shows 116 prescription claims across 31 beneficiaries totaling $1,302 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). Open Payments data shows 2 records totaling $84. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $78,167 to $723,901. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,695 and ending at $1,302. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$362K$724K2015 Medicare payment: $78,167 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $79,127 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $80,976 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $90,661 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $63,046 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $102,610 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $188,408 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $211,937 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $313,676 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $723,901 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151141,048$78,167
20161281,146$79,127
2017891,057$80,976
2018951,144$90,661
201985669$63,046
2020971,620$102,610
2021783,490$188,408
20221273,355$211,937
20231132,841$313,676
20241244,490$723,901

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.7K$5.5K2015 Drug cost: $1,695 (USD; Tot_Drug_Cst)2016 Drug cost: $2,987 (USD; Tot_Drug_Cst)2017 Drug cost: $1,084 (USD; Tot_Drug_Cst)2018 Drug cost: $2,334 (USD; Tot_Drug_Cst)2019 Drug cost: $1,195 (USD; Tot_Drug_Cst)2020 Drug cost: $2,997 (USD; Tot_Drug_Cst)2021 Drug cost: $5,455 (USD; Tot_Drug_Cst)2022 Drug cost: $3,871 (USD; Tot_Drug_Cst)2023 Drug cost: $1,508 (USD; Tot_Drug_Cst)2024 Drug cost: $1,302 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153478$1,695
201638115$2,987
20172953$1,084
20183380$2,334
20193375$1,195
20203660$2,997
20213992$5,455
202237103$3,871
202341107$1,508
202431116$1,302

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
77427Radiation treatment management, 5 treatment sessions50336$145
77014Ct guidance for insertion of radiation therapy fields441,493$89
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more5075$76
77336Continuing radiation therapy consultation per week50303$66
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5878$60

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Tamsulosin HclTamsulosin Hcl733,385$705
Oxybutynin ChlorideOxybutynin Chloride25970$400

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$84Siemens Medical Solutions USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Carlos P. Torres, M.D.?

Tedicare shows public-source Medicare data for Carlos P. Torres, M.D. (NPI 1396701819), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carlos P. Torres, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Carlos P. Torres, M.D.?

Carlos P. Torres, M.D. is linked to TEXAS ONCOLOGY PA (billing NPI 1811944101) in the available physician profile data.

Does Carlos P. Torres, M.D. have Open Payments data?

Carlos P. Torres, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.